Published in Environ Int on July 06, 2017
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology (1992) 6.03
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol (2011) 3.45
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol (2009) 3.02
Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis (1993) 2.48
The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol (1991) 2.36
Health effects of chronic pesticide exposure: cancer and neurotoxicity. Annu Rev Public Health (2004) 2.35
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24
Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord (2002) 2.21
Clinical characteristics in early Parkinson's disease in a central California population-based study. Mov Disord (2005) 2.19
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology (2007) 1.97
Occupational exposure to pesticides increases the risk of incident AD: the Cache County study. Neurology (2010) 1.95
Effects of 5' regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet (2001) 1.85
Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. Environ Health Perspect (2005) 1.79
In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology (1995) 1.72
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71
Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol (2003) 1.65
Validation of a 26-point telephone version of the Mini-Mental State Examination. J Geriatr Psychiatry Neurol (2004) 1.65
Prognostic factors for the progression of Parkinson's disease: a systematic review. Mov Disord (2007) 1.52
Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism. Annu Rev Med (2001) 1.51
Serum cholesterol levels and the risk of Parkinson's disease. Am J Epidemiol (2006) 1.49
Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer's disease and vascular dementia. Am J Alzheimers Dis Other Demen (2014) 1.40
Neurologic symptoms in licensed pesticide applicators in the Agricultural Health Study. Hum Exp Toxicol (2007) 1.33
α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease. PLoS One (2012) 1.33
What predicts mortality in Parkinson disease?: a prospective population-based long-term study. Neurology (2010) 1.30
Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology (2010) 1.30
The epidemiology of dementia associated with Parkinson's disease. Brain Pathol (2010) 1.26
Current opinion on the science of organophosphate pesticides and toxic stress: a systematic review. Med Sci Monit (2009) 1.26
Suicide and exposure to organophosphate insecticides: cause or effect? Am J Ind Med (2005) 1.21
Linking pesticide exposure and dementia: what is the evidence? Toxicology (2013) 1.16
Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms. Pharmacol Ther (2012) 1.15
The clinical progression of Parkinson's disease. Parkinsonism Relat Disord (2009) 1.14
Polymorphisms in the PON gene cluster are associated with Alzheimer disease. Hum Mol Genet (2005) 1.08
Developmental neurotoxicants target neurodifferentiation into the serotonin phenotype: Chlorpyrifos, diazinon, dieldrin and divalent nickel. Toxicol Appl Pharmacol (2008) 1.06
Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain. Neurotoxicology (2007) 1.03
Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol Aging (2004) 1.03
Neurobehavioral problems following low-level exposure to organophosphate pesticides: a systematic and meta-analytic review. Crit Rev Toxicol (2012) 1.02
α-Synuclein gene may interact with environmental factors in increasing risk of Parkinson's disease. Neuroepidemiology (2010) 1.02
Determinants of plasma coenzyme Q10 in humans. FEBS Lett (1999) 1.01
Genetic and other sources of variation in the activity of serum paraoxonase/diazoxonase in humans: consequences for risk from exposure to diazinon. Pharmacogenet Genomics (2005) 0.99
Pesticide exposure and Parkinson's disease: epidemiological evidence of association. Neurotoxicology (2012) 0.99
Alpha-synuclein oligomerization: a role for lipids? Trends Neurosci (2003) 0.94
Association between PON1 activity and coronary heart disease risk: a meta-analysis based on 43 studies. Mol Genet Metab (2011) 0.92
Diagnostic accuracy and agreement across three depression assessment measures for Parkinson's disease. Parkinsonism Relat Disord (2010) 0.91
The interrelation between organophosphate toxicity and the epidemiology of depression and suicide. Rev Environ Health (2007) 0.90
Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure. Environ Int (2013) 0.88
Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clin Biochem (2009) 0.88
The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease. Front Aging Neurosci (2015) 0.87
Pesticides that inhibit the ubiquitin-proteasome system: effect measure modification by genetic variation in SKP1 in Parkinson׳s disease. Environ Res (2013) 0.85
Paraoxonase 1 192/55 gene polymorphisms in Alzheimer's disease. Ann N Y Acad Sci (2002) 0.84
The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Women's Heart and Health Study. J Epidemiol Community Health (2007) 0.82
Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson's disease: a HuGE review and meta-analysis. Gene (2012) 0.81
Paraoxonase 1 gene polymorphisms and dementia in humans. Neurosci Lett (2004) 0.80
Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene-Pesticide Interactions in a Case-Control Study of Parkinson's Disease, California (USA). Environ Health Perspect (2015) 0.79
Paraoxonase activity and dementia. J Neurol Sci (2009) 0.79
Meta-analysis on occupational exposure to pesticides--neurobehavioral impact and dose-response relationships. Environ Res (2014) 0.78
Paraoxonase 1 (PON1) gene-108C>T and p.Q192R polymorphisms and arylesterase activity of the enzyme in patients with dementia. Folia Neuropathol (2013) 0.77
Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions. Ann Med (1991) 0.76
PON-1 and ferroxidase activities in older patients with mild cognitive impairment, late onset Alzheimer's disease or vascular dementia. Clin Chem Lab Med (2015) 0.76
Lowered plasma paraoxonase (PON)1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J Affect Disord (2014) 0.76
The paraoxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or INCHIANTI studies. Int J Epidemiol (2009) 0.76
Cognitive decline, mortality, and organophosphorus exposure in aging Mexican Americans. Environ Res (2017) 0.75